Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.7 - $5.28 $76,185 - $148,985
-28,217 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$4.29 - $6.64 $121,050 - $187,360
28,217 New
28,217 $142,000
Q2 2021

Aug 16, 2021

SELL
$5.06 - $10.78 $51,738 - $110,225
-10,225 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$5.64 - $23.33 $57,669 - $238,549
10,225 New
10,225 $62,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $75.9M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.